HomeCLBT • NASDAQ
Cellebrite DI Ltd
$10.88
After Hours:
$10.90
(0.17%)+0.019
Closed: Apr 26, 4:08:18 PM GMT-4 · USD · NASDAQ · Disclaimer
StockUS listed security
Previous close
$10.71
Day range
$10.71 - $10.89
Year range
$5.22 - $12.50
Market cap
2.23B USD
Avg Volume
910.76K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD)Dec 2023Y/Y change
Revenue
88.53M68.16%
Operating expense
63.10M20.85%
Net income
-14.65M-306.94%
Net profit margin
-16.55-223.14%
Earnings per share
0.1250.00%
EBITDA
17.97M317.47%
Effective tax rate
-18.65%
Total assets
Total liabilities
(USD)Dec 2023Y/Y change
Cash and short-term investments
302.92M64.97%
Total assets
532.88M32.13%
Total liabilities
498.67M51.38%
Total equity
34.21M
Shares outstanding
205.26M
Price to book
63.00
Return on assets
7.36%
Return on capital
75.57%
Net change in cash
(USD)Dec 2023Y/Y change
Net income
-14.65M-306.94%
Cash from operations
43.83M22.62%
Cash from investing
3.16M108.44%
Cash from financing
4.53M128.33%
Net change in cash
52.45M1,603.51%
Free cash flow
30.63M157.70%
About
Cellebrite DI Ltd. is an Israeli digital intelligence company that provides tools for federal, state, and local law enforcement as well as enterprise companies and service providers to collect, review, analyze and manage digital data. On April 8, 2021, Cellebrite announced plans to go public via a merger with a blank-check firm, valuing the company at approximately $2.4 billion. Their flagship product series is the Cellebrite UFED. Wikipedia
Founded
1999
Employees
1,008
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu